Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Opioids

Therapeutic area intelligence for Opioids with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Companies

ClinicalAugust 8, 2026

This study compares the Eleveld and Minto TCI models for remifentanil to assess differences in analgesia levels.

ClinicalJuly 20, 2026

The Opioid Rapid Response System (ORRS) project aims to train citizens in naloxone administration to reduce opioid overdose deaths.

RegulatoryJune 28, 2026

The FDA has accepted a supplemental NDA for MS CONTIN, containing morphine sulfate, submitted by KNOA PHARMA.

No catalysts indexed for this entity yet.

No related entities indexed yet.

Newsletter

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.